Cutler Group LP Abbott Laboratories Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Abbott Laboratories stock. As of the latest transaction made, Cutler Group LP holds 1,900 shares of ABT stock, worth $223,744. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,900

Previous 1,081 75.76%

Holding current value

$223,744

Previous $118,000 52.54%

% of portfolio

0.02%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$90.19 - $110.4 $93,707 - $114,705	1,039 Added 2473.81%	1,081 $118,000
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $58,273 - $69,918	-610 Reduced 93.56%	42 $4,000
Q2 2023 Jul 18, 2023	SELL	$100.78 - $112.29 $411,484 - $458,480	-4,083 Reduced 86.23%	652 $71,000
Q1 2023 May 01, 2023	SELL	$96.86 - $114.01 $348,696 - $410,436	-3,600 Reduced 43.19%	4,735 $479,000
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $38,974 - $45,723	410 Added 5.17%	8,335 $915,000
Q3 2022 Oct 25, 2022	SELL	$96.76 - $112.03 $309,341 - $358,159	-3,197 Reduced 28.74%	7,925 $766,000
Q2 2022 Aug 04, 2022	BUY	$102.07 - $123.37 $997,428 - $1.21 Million	9,772 Added 723.85%	11,122 $1.21 Million
Q1 2022 Apr 14, 2022	SELL	$114.02 - $139.04 $989,579 - $1.21 Million	-8,679 Reduced 86.54%	1,350 $159,000
Q4 2021 Jan 18, 2022	BUY	$115.53 - $141.46 $1.02 Million - $1.25 Million	8,829 Added 735.75%	10,029 $1.41 Million
Q3 2021 Oct 26, 2021	BUY	$116.66 - $129.06 $46,664 - $51,624	400 Added 50.0%	1,200 $141,000
Q2 2021 Jul 19, 2021	BUY	$105.79 - $124.53 $84,632 - $99,624	800 New	800 $92,000
Q1 2021 Apr 26, 2021	SELL	$108.84 - $128.23 $10,884 - $12,822	-100 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$105.0 - $114.42 $296,205 - $322,778	-2,821 Reduced 96.58%	100 $10,000
Q3 2020 Oct 27, 2020	BUY	$91.64 - $111.29 $9,164 - $11,129	100 Added 3.54%	2,921 $317,000
Q2 2020 Jul 22, 2020	BUY	$76.57 - $98.0 $30,627 - $39,200	400 Added 16.52%	2,821 $257,000
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $18,846 - $27,558	-300 Reduced 11.03%	2,421 $191,000
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $360,360 - $401,166	-4,590 Reduced 62.78%	2,721 $236,000
Q3 2019 Oct 28, 2019	BUY	$81.84 - $88.74 $383,829 - $416,190	4,690 Added 178.94%	7,311 $611,000
Q2 2019 Aug 09, 2019	BUY	$72.88 - $85.0 $72,880 - $85,000	1,000 Added 61.69%	2,621 $220,000
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $74,232 - $89,747	1,121 Added 224.2%	1,621 $129,000
Q4 2018 Feb 05, 2019	BUY	$65.56 - $74.27 $31,403 - $35,575	479 Added 2280.95%	500 $36,000
Q3 2018 Nov 07, 2018	SELL	$60.81 - $73.36 $175,071 - $211,203	-2,879 Reduced 99.28%	21 $1,000
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $91,363 - $100,837	-1,587 Reduced 35.37%	2,900 $176,000
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $254,565 - $287,816	-4,524 Reduced 50.21%	4,487 $268,000
Q4 2017 Jan 17, 2018	SELL	$53.68 - $57.47 $10,736 - $11,494	-200 Reduced 2.17%	9,011 $514,000
Q3 2017 Oct 17, 2017	BUY	$48.06 - $53.64 $442,680 - $494,078	9,211	9,211 $491,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account